Your Strength. Our Knowledge and Experience.

1. Transitional Cell Carcinoma (Urothelial Carcinoma): The most common type, originating in the bladder’s inner lining.

2. Squamous Cell Carcinoma: Less common, often linked to irritation and inflammation of the bladder.

3. Adenocarcinoma: A rare form that develops from glandular cells in the bladder.

4. Small Cell Carcinoma: A rare and aggressive type that resembles small cell lung cancer.

1. Medical History and Physical Examination: A healthcare provider will assess symptoms and perform a physical exam.

2. Urinalysis: A urine test can reveal blood (hematuria) or abnormal cells.

3. Cystoscopy: A thin tube with a camera is inserted into the bladder to visually inspect for tumors or abnormalities.

4. Biopsy: If abnormal tissue is found, a biopsy may be conducted during cystoscopy to confirm the presence of cancer.

5. Imaging Tests: CT scans, MRIs, or ultrasounds may be used to evaluate the extent of the disease.

Signs and Symptoms

• Blood in Urine (Hematuria): The most common symptom.
• Frequent Urination: A strong urge to urinate more often than usual.
• Painful Urination: Discomfort or burning sensation while urinating.
• Lower Abdominal Pain: Discomfort in the bladder or pelvic area.
• Back Pain: Pain in the lower back may also occur in advanced stages.

Risk Factors

1. Smoking: The leading risk factor associated with bladder cancer.
2. Chemical Exposure: Contact with certain chemicals, especially in industrial settings.
3. Chronic Irritation: Repeated urinary tract infections or bladder inflammation.
4. Family History: A genetic predisposition can increase risk.
5. Age and Gender: More common in older adults and men.

This information provides a snapshot of bladder cancer, covering essential aspects for better understanding.

• Surgery:
  Transurethral Resection (TURBT): A common procedure to remove tumors.
  Cystectomy: Removal of part or all of the bladder in advanced cases.
• Chemotherapy:
  Used to kill cancer cells or prevent them from growing, either before or after surgery.
• Immunotherapy:
  Treatments that help the immune system recognize and attack cancer cells.
• Radiation Therapy:
  Can be used in conjunction with other treatments or for patients who cannot undergo surgery.
• Targeted Therapy:
  Newer drugs target specific characteristics of cancer cells to block their growth.

Following your initial consultation with the El Portal team, where your treatment plan is outlined and questions are answered, you’ll be scheduled for a chemotherapy education class. This class will give you essential information about what to anticipate during your treatments, including the duration of appointments, the procedures involved, and resources for addressing questions or side effects after hours.

During this class, you will also meet with a dedicated Patient Financial Counselor who will discuss treatment costs, insurance pre-authorization, and any financial concerns you may have. Once your insurance authorizes your treatment, our office staff will contact you to schedule your first chemotherapy session.

Preparing for Your First Chemotherapy Appointment

Your care team will provide specific instructions for preparing for your first treatment, but in general, preparation is minimal. Drinking plenty of water the day before treatment is recommended, and it is advisable to eat a light meal prior to your appointment. Packing a snack may also help alleviate potential nausea. It’s a good idea to have someone drive you to and from your appointment in case you experience fatigue or nausea afterward.

During your first visit, you will be weighed and have your vital signs checked to ensure it is safe to proceed with chemotherapy. An oncology nurse will insert an IV into your hand or arm, or connect an IV line to your pre-implanted port, if applicable. The chemotherapy drugs will be administered through the IV in a slow, continuous manner. As you receive treatment, you can relax in one of our spacious, light-filled treatment bays equipped with reclining chairs and WiFi access.

Each session may require several hours, so bringing a book or something to watch can make the time more enjoyable. Snacks and water are permitted, and you can make use of the restroom as needed throughout the treatment.

When you’re referred to EPCCC, your medical oncologist and a team of cancer specialists will create a personalized treatment plan tailored to your specific circumstances, considering factors such as:

• Type and grade of your cancer
• Size and location of your tumor
• Sensitivity of surrounding tissues
• Genetic factors
• Family medical history
• Your age, overall health, and previous medical history
• Your treatment goals and preferences

What to Expect During Chemotherapy Treatments

After your initial meeting with your cancer care team to discuss your treatment plan and address any questions, you will be scheduled to attend a chemotherapy education class at El Portal Comprehensive Cancer Centers. This session will provide valuable insights into what you can anticipate from chemotherapy treatment. You will also have the opportunity to meet privately with one of our dedicated cancer financial counselors to discuss treatment costs, insurance coverage, and potential financial assistance.

Your regular chemotherapy treatments will vary based on the specific type of therapy prescribed. Some chemotherapy drugs are given via injection, which is quick, while most are delivered through intravenous infusion, allowing the medication to enter your veins in a slow, continuous manner.

One of the most frequently reported side effects among cancer patients is fatigue. This deep-seated tiredness—often referred to as cancer-related fatigue—can differ significantly from the fatigue experienced by healthy individuals. It can manifest suddenly or gradually, and may not improve with rest. In some cases, fatigue may be compounded by other factors such as anemia and pain. The encouraging news is that this fatigue typically resolves within weeks following the conclusion of treatment.

While side effects will vary by cancer type and individual patient responses, not everyone will experience the same issues. It’s essential to approach this variability with mindfulness and not to expend excessive energy worrying about potential side effects.

Chemotherapy side effects may include:

• Mental fog, often described as “chemo brain,” leading to forgetfulness and difficulty concentrating
• Hair loss
• Easy bruising or bleeding
• Increased susceptibility to infections (bacterial, viral, or fungal)
• Anemia (low red blood cell count)
• Nausea and vomiting
• Loss of appetite
• Constipation and diarrhea
• Pain
• Oral health issues, such as dry mouth, sores, and difficulty swallowing
• Nerve and muscle concerns, including numbness and weakness
• Changes to skin and nails, such as dryness and cracking
• Altered urinary characteristics, affecting color and smell
• Weight loss
• Changes in memory and concentration
• Mood fluctuations
• Alterations in libido and sexual function
• Potential fertility challenges
• Heart-related concerns

In certain cases, chemotherapy may be the sole treatment required. However, it is frequently used in conjunction with other therapies, such as surgery or radiation therapy, to maximize chances of success.

• Neoadjuvant Chemotherapy: Administered before surgery to shrink tumors or halt cancer spread, making surgical procedures less invasive and more effective.
• Concurrent Treatment: Involving chemotherapy or immunotherapy given simultaneously with radiation therapy.
• Adjuvant Chemotherapy: Given after surgery to eliminate any remaining cancer cells, aimed at reducing recurrence risk.

Who Will Oversee Your Chemotherapy?

Your treatment will be overseen by a medical oncologist, a specialist who evaluates your cancer diagnosis and all available treatment options, creating a personalized plan tailored to your needs. As the “quarterback” of your care team at El Portal Comprehensive Cancer Centers, your oncologist will determine chemotherapy’s appropriateness based on several factors, including tumor type, stage, size, and personal considerations.

Your oncologist works alongside a diverse team of healthcare professionals, including radiation oncologists and surgeons, to coordinate your overall care seamlessly. During treatment sessions, a specially trained oncology nurse will administer chemotherapy, monitor your health, address your questions, and assist you in managing any side effects.

Adopting a healthy lifestyle during cancer treatment can help mitigate some side effects and improve your overall well-being. Here are several strategies to consider for managing chemotherapy side effects:

1. Prioritize Rest: Cancer treatment can be exhausting. Make sure to get ample rest, delegate tasks when necessary, and don’t hesitate to ask for help.
2. Stay Active When Possible: While rest is essential, gentle physical activity can enhance energy levels, improve circulation, reduce stress, and maintain muscle strength. Discuss suitable activities with your healthcare provider to find what works best for you.
3. Communicate About Medications: Some medications can interact negatively with cancer treatments. Inform your care team about all the medications you’re taking, including over-the-counter drugs, supplements, and vitamins.
4. Care for Your Skin: If you experience dryness or irritation from treatment, use gentle skincare products. Warm baths with baby oil and fragrance-free lotions can provide relief. Protect your skin from extreme temperatures and stay hydrated.
5. Recognize Your Emotions: The emotional toll of cancer treatment is significant. Feelings of anxiety, anger, sadness, or isolation are common. Engaging with support groups, whether in-person or online, can provide valuable connection and understanding. At El Portal Comprehensive Cancer Centers (EPCCC), we offer resources to help you cope with the emotional aspects of treatment, including support groups and access to licensed clinical oncology social workers. If you find your feelings overwhelming, be sure to discuss them with your care team.

Thanks to recent developments in treatment, many patients find that the severity of chemotherapy side effects has diminished over the years. New medications are also available to help manage side effects, but occasionally, these medications may bring their own challenges.

In certain cases, side effects may signal more serious complications. If you experience any of the following worsening symptoms, please reach out to your care team at EPCCC for guidance (unless experiencing a life-threatening emergency). Our board-certified medical oncologists and specially trained nurses are well-equipped to evaluate your symptoms and recommend appropriate interventions.

If you encounter any of the following issues, our medical professionals are available 24/7 to assist:

• Fever of 100.4°F (38°C) or higher
• Unexplained bruising or bleeding
• Severe rashes or itching
• Swelling in the mouth or throat, along with mouth sores or trouble swallowing
• Swelling in the neck, shoulder, arms, or legs, especially if asymmetrical
• Intense chills
• Unmanaged pain at injection or catheter sites
• Unusual pain, including severe headaches
• Difficulty breathing (immediate emergency care is needed)
• Persistent diarrhea or vomiting
• Blood in stool or urine
• Severe fatigue
• Burning sensation during urination, with lower back pain (potential UTI)
• Productive cough with colored sputum
• Unresolved diarrhea, constipation, nausea, or vomiting
• Dizziness or lightheaded
• Numbness, tingling (feeling of pins and needles) of hands and/or feet

Dr. Mahmoudieh has been a vital member of El Portal Comprehensive Cancer Centers since 2008, bringing over a decade of dedicated experience to patient care. Before joining our team, he served as the Director of the Prostate Brachytherapy Program at Kaiser Permanente in Sacramento and Roseville, demonstrating his leadership in advanced cancer treatments.

He earned his medical degree from the Albert Szent-Györgyi School of Medicine in Szeged, Hungary, in 1996. With a strong interest in treating head, neck, and breast cancers, Dr. Mahmoudieh specializes in cutting-edge techniques such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT). His expertise extends to treating cancers of the head and neck, lung, gastrointestinal tract, and prostate.

A committed professional, Dr. Mahmoudieh is a member of the American Society for Therapeutic Radiology and Oncology (ASTRO), reflecting his engagement with ongoing developments in cancer treatment and research. His compassionate approach and advanced skill set ensure that each patient receives personalized, state-of-the-art care.

Outside of his professional life, Dr. Mahmoudieh enjoys traveling with his son and daughter, as well as reading and playing racquetball, embracing a balanced and active lifestyle. His dedication to both his patients and his personal passions makes him a trusted partner in your journey toward health.

Dr. Elhanafy is a highly respected Associate Professor of Medical Physics and serves as the Chief Medical Physicist at El Portal Comprehensive Cancer Centers since July 2013. He earned his Ph.D. in Medical Physics from the University of Wisconsin, Madison—where he began his foundational training and completed his thesis—in 2013, building on his initial joining of the university in 1999.

 With specialized training in advanced radiation oncology techniques—such as Intensity-Modulated Radiation Therapy (IMRT), High-Dose Rate Brachytherapy (HDR), Stereotactic Radiosurgery (SRS), Total Body Irradiation (TBI), Quality Assurance, and Radiobiology—Dr. Elhanafy brings a wealth of expertise to patient care. His dedication to the field is evident through numerous published research articles, as well as awards recognizing his leadership in organizing conferences, training sessions, lectures, and workshops.

Beyond his impressive credentials, Dr. Elhanafy is deeply committed to advancing medical physics and ensuring the best possible outcomes for his patients. His compassionate approach, combined with his extensive knowledge, makes him a trusted partner in your cancer care journey.

Outside of his professional pursuits, he values spending quality time with his family, reflecting his genuine care and balance in life.

Dr. Ahuja is a distinguished, board-certified Medical Oncologist with extensive training in medical hematology. He has refined his expertise at renowned institutions such as Tata Memorial Hospital, UCLA School of Medicine, and Roswell Park, under the mentorship of esteemed hematologists including Dr. S.H. Advani, Dr. Michael Caligiuri, and Dr. M.J. Cline.

With over 25 years of experience in both hematology and oncology, Dr. Ahuja offers a deep well of knowledge and a compassionate approach to patient care at El Portal Cancer Center. His dedication to advancing the field is reflected through active membership in prestigious professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Indian Society of Medical and Pediatric Oncology.

A passionate researcher, Dr. Ahuja has contributed significantly to ongoing scientific advancements—serving on the NRG Breast Committee and the Rare Subtype Committee, and acting as Principal Investigator for the “CROWN” NCORP study. His commitment to clinical excellence and groundbreaking research underscores his dedication to improving outcomes for his patients.

Outside of his professional pursuits, Dr. Ahuja values spending quality time with his family, and enjoys hiking and traveling, embracing life outside the clinic with the same dedication he brings to his medical practice. His compassionate nature and extensive experience make him a trusted partner in your cancer care journey.

Dr. Crain is a highly experienced and board-certified Medical Oncologist and Hematologist with over 45 years of dedicated service in the medical field. Throughout his distinguished career, he has established himself as a leading expert in the diagnosis, treatment, and prevention of various cancers and blood disorders.

He earned his medical degree from the University of Illinois College of Medicine in 1977 and is actively affiliated with esteemed institutions, including Adventist Health St. Helena. Dr. Crain’s extensive experience spans a broad range of conditions, including small intestine and colorectal cancers, breast cancer, prostate cancer, anemia, leukemia, and lymphoma.

Beyond his clinical expertise, Dr. Crain is deeply committed to advancing medical research and improving patient care. His approach to treatment is rooted in compassion and a thorough understanding of complex medical conditions, ensuring each patient receives personalized, comprehensive care.

Recognized for his empathetic nature and unwavering dedication, Dr. Crain strives to achieve the best possible outcomes for his patients and foster a trusting, supportive environment. His lifelong commitment to the fields of oncology and hematology reflects his passion for making a meaningful difference in his patients’ lives.

Michael Kangas serves as the Director of Oncology and Diagnostic Imaging, where he spearheads initiatives that enhance revenue, profitability, productivity, and patient satisfaction within an underserved area. His leadership is instrumental in developing and guiding a highly skilled team of healthcare professionals across multiple clinics, providing comprehensive cancer care and diagnostic imaging services utilizing the most advanced technology. Michael’s commitment is rooted in delivering personalized, high-quality care to each patient, ensuring they receive the support they need throughout their journey.

With extensive expertise in Health Information Management, Electronic Medical Records (EMR), Radiation Therapy, Radiation Oncology, Clinical Operations, Healthcare Compliance, and Regulatory Standards, Michael ensures that all services meet the highest industry standards. He also focuses on monitoring performance, healthcare marketing, and supervisory skills to foster a collaborative, efficient, and patient-centered environment.

In addition to his clinical leadership, Michael actively volunteers with the Merced Cancer Society Foundation as its Executive Director. In this role, he oversees key operational and administrative functions to advance the foundation’s mission of positively impacting residents in the Central Valley. His efforts include community outreach, organizing fundraising events, and leading initiatives to expand the foundation’s support and resources for local cancer patients.

Michael’s dedication to improving healthcare and strengthening community ties highlights his unwavering commitment to healing, hope, and making a meaningful difference in the lives of those he serves.

What is Gynecologic Cancer?

Gynecologic cancer refers to cancers affecting the female reproductive system. The five primary types include ovarian, cervical, endometrial, vulvar, and vaginal cancers. Each type presents distinct characteristics, yet early detection remains critical for effective treatment.

Types of Gynecologic Cancers

The six primary types of gynecologic cancers include:

1. Cervical:Originates in the cervix, the lower end of the uterus leading to the vagina.
2. Ovarian:Begins in the ovaries, the female reproductive glands located on either side of the uterus.
3. Uterine (Endometrial):Arises in the uterus, the organ where fetal development occurs.
4. Vaginal:Develops in the vagina, the channel between the uterus and the outside of the body.
5. Vulvar:Occurs on the vulva, the external part of the female genitalia.
6. Tubal:Begins in the fallopian tubes.

While treatment options will vary according to cancer type, tumor grade, and cancer stage, surgery is nearly always a crucial component. Many treatment plans also include chemotherapy and/or radiation therapy. At El Portal Cancer Centers, our team works collaboratively—our surgeon, medical oncologists, and radiation oncologists join forces to ensure you receive the most comprehensive and integrated care possible.

What are the Risk Factors?

All women face a risk of developing gynecologic cancers, and this risk increases with age. While some risk factors are controllable, others are not.

Commonly associated controllable risk factors include:

• Human papillomavirus (HPV) infection
• Long-term oral contraceptive use
• Being overweight or obese
• Poor nutrition
• Smoking
• Exposure to diethylstilbestrol (DES)
• Human immunodeficiency virus (HIV/AIDS) infection

In addition to making lifestyle changes—such as maintaining a balanced diet and exercising regularly—discussing your concerns with your doctor can lead to proactive measures for risk reduction, like the HPV vaccine.

Unfortunately, some risk factors are beyond your control, including age, race, and family history. It’s essential to remember that many women with risk factors never develop gynecologic cancer. If there is a family history of certain cancers, consider discussing genetic testing options with your healthcare provider.

What Symptoms Should I Watch For?

Being aware of potential symptoms can help facilitate early detection. Some symptoms include:

• Abnormal vaginal bleeding or discharge
• Pelvic pain
• Pain during intercourse
• Frequent or urgent bowel changes
• Bloating or a feeling of fullness

If you experience any of these symptoms for more than a month, we strongly recommend scheduling an appointment with your gynecologist. Regular check-ups are vital, even in the absence of symptoms.

What Should I Ask My Doctor?

Establishing an open dialogue with your doctor is crucial for understanding gynecologic cancer. Consider asking:

• What is a Pap test, and why is it necessary?
• How often should I schedule Pap tests?
• What do my Pap results mean?
• Is an HPV test appropriate for me?
• When can I discontinue Pap testing?

How are Gynecologic Cancers Treated? A treatment plan for gynecologic cancers is tailored to each individual. Surgery is generally the first step, often followed by a combination of chemotherapy and/or radiation therapy. Our specialists collaborate closely to ensure every aspect of your treatment is addressed thoroughly.

Are All Gynecologic Conditions Cancerous? Not all gynecological conditions are cancerous. Many benign conditions may resolve on their own or can be treated effectively. Examples include fibroids, ovarian cysts, and pelvic infections, each of which may require specific management based on severity.

Robotic-Assisted Surgery and Gynecologic Care

At El Portal Cancer Centers, we offer robotic-assisted surgery, a minimally invasive option that reduces recovery time and minimizes surgical trauma. This advanced approach allows for precise procedures through smaller incisions, resulting in less pain and scarring, lower infection risks, and quicker returns to daily activities.

Minimally Invasive Surgery Options

• Laparoscopic Surgery:A gold standard in gynecologic procedures, this technique involves small incisions and utilizes a camera to guide the surgeon.\
• Robotic-Assisted Surgery: A New Era in Gynecologic CareThe landscape of gynecologic surgery has transformed significantly. At El Portal Cancer Centers (EPCC), we are proud to offer robotic-assisted surgery, a forward-thinking option that allows for minimally invasive procedures with enhanced precision and improved outcomes. This advanced technique utilizes specialized robotic instruments coupled with a unique 3D high-definition view of the surgical site, empowering your surgeon to perform with remarkable accuracy.

Pros of Concurrent Treatment:

• Enhanced Effectiveness: Research indicates that combining chemotherapy with radiation therapy can enhance the overall effectiveness of treatment. This is particularly true for certain cancers, including brain, head and neck, gastrointestinal, bladder, and lung cancers. When these cancers are located in challenging areas of the body, concurrent treatment can improve the chances of successful outcomes.
• Coordinated Care: At El Portal Comprehensive Cancer Centers (EPCCC), our experienced team of board-certified medical oncologists and radiation oncologists work closely together to ensure that your treatment is well-coordinated. This collaborative approach helps to minimize potential interactions between therapies.

Cons of Concurrent Treatment:

• Increased Side Effects: While concurrent treatment can be more effective against cancer, it can also place added stress on your body. Patients often experience intensified side effects such as nausea, fatigue, pain, and hair loss. These heightened reactions can be challenging and require careful management.
• More Frequent Appointments: Receiving both chemotherapy and radiation at the same time typically involves more appointments in a shorter timeframe. This means additional monitoring, including scans and blood draws, which can add to the overall stress of the treatment process.

Given the potential challenges associated with concurrent treatment, many patients may find that their treatment plan recommends therapies to be administered sequentially rather than simultaneously. A comprehensive approach may include surgery, chemotherapy, radiation therapy, immunotherapy, or targeted therapy—either alone or in combination.

Neoadjuvant Therapy: When chemotherapy or radiation is administered before surgery, the goal is to shrink the tumor or eliminate cancer cells outside the primary tumor site. This is known as neoadjuvant therapy and can enhance the effectiveness of surgical intervention.

Adjuvant Therapy: Conversely, if chemotherapy or radiation is administered after surgery, it serves the purpose of targeting any residual cancer cells that may remain, thus reducing the risk of recurrence. This approach is called adjuvant therapy.

By spacing out treatments, your body has the opportunity to recover between therapies, often resulting in fewer and less severe side effects.

Conclusion

Navigating cancer treatment options can be overwhelming, and each patient’s circumstances are unique. It’s important to discuss your individual situation with your healthcare team to determine the best approach tailored to your needs. Understanding the pros and cons of concurrent treatment, as well as the benefits of sequential therapies, can empower you to make informed decisions about your care. Remember, you are not alone in this journey, and a supportive team is here to help guide you every step of the way.

Hodgkin lymphoma (HL) can present with various signs and symptoms, which may evolve over time. Common symptoms include:

1. Swollen Lymph Nodes: The most prominent sign is usually painless swelling of lymph nodes in the neck, armpit, or groin. These nodes may feel firm or rubbery.
2. Fever: Patients may experience persistent fevers without an infectious cause, often referred to as “B symptoms.”
3. Night Sweats: Drenching night sweats that can soak clothing and bedding, often severe and uncomfortable.
4. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) over a short period without changes in diet or exercise.
5. Fatigue: Persistent fatigue or lack of energy that does not improve with rest.
6. Itching: Generalized itching (pruritus) can occur without a rash and may be bothersome.
7. Chest Pain or Cough: If the lymphoma affects areas in the chest, individuals may experience chest pain, persistent cough, or difficulty breathing.
8. Abdominal Pain or Swelling: Involvement of the abdomen may lead to pain or a sense of fullness due to enlarged lymph nodes or spleen.
9. Alcohol-Induced Pain: Some patients report pain in lymph nodes after consuming alcohol, which is quite specific to Hodgkin lymphoma.

Several factors can increase the risk of developing Hodgkin lymphoma:

1. Age: Hodgkin lymphoma is most commonly diagnosed in young adults aged 15-35 and older adults aged 55 and above.
2. Gender: It is more common in males than females.
3. Family History: A family history of Hodgkin lymphoma or other related cancers may increase risk.
4. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS or those on immunosuppressive therapy, have an increased risk.
5. Viral Infections: Infections with the Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV) are associated with an elevated risk.
6. Geographic Location: There are geographic variations in HL incidence, with higher rates reported in certain regions.
7. Obesity: Some studies suggest a potential link between obesity and an increased risk of Hodgkin lymphoma.
8. Previous Radiation Therapy: Individuals who received radiation therapy for other cancers, especially during childhood, may have a heightened risk.

The treatment of Hodgkin lymphoma (HL) often depends on the stage of the disease, tumor characteristics, the patient’s age, and overall health. Common treatment options include:

1. Chemotherapy: Chemotherapy is the cornerstone of treatment for Hodgkin lymphoma. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), which is effective in most patients.
2. Radiation Therapy: Radiation therapy may be used alone or in combination with chemotherapy, especially for localized disease (early-stage HL). It targets specific areas affected by lymphoma.
3. Stem Cell Transplant: For patients with relapsed or refractory Hodgkin lymphoma, high-dose chemotherapy followed by autologous stem cell transplantation may be considered. This allows for the use of higher doses of chemotherapy to effectively destroy cancer cells.
4. Immunotherapy: Newer targeted therapies, including monoclonal antibodies (like brentuximab vedotin), use the body’s immune system to fight cancer. This option may be used in certain cases of relapsed or refractory HL.
5. Clinical Trials: Participation in clinical trials may provide access to innovative therapies and new treatment approaches that are not yet widely available.
6. Supportive Care: Management of side effects and supportive care to maintain quality of life during treatment are crucial. This may include medication for nausea, pain management, and counseling services.

1. Hodgkin Lymphoma: The overall 5-year survival rate for Hodgkin lymphoma is approximately 87%, with a significant number of patients achieving long-term remission. Cure rates in early-stage HL can be even higher, exceeding 90%with appropriate treatment.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

Non-Hodgkin Lymphoma (NHL) can present with a variety of signs and symptoms, which may vary depending on the subtype of NHL and the areas of the body affected. Common signs and symptoms include:

1. Lymphadenopathy: Swollen lymph nodes, particularly in the neck, armpits, or groin. These may feel rubbery or firm and are often painless.
2. Fever: Persistent fevers without an obvious cause, sometimes with chills.
3. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) without trying or without an underlying reason.
4. Night Sweats: Drenching night sweats that may soak through clothing and bedding.
5. Fatigue: Chronic fatigue or weakness that doesn’t improve with rest.
6. Abdominal Pain or Swelling: Pain or discomfort in the abdomen, which may also be associated with a swollen abdomen due to enlarged lymph nodes or spleen.
7. Chest Pain: If lymphoma affects the chest area, it can cause chest pain, coughing, or difficulty breathing.
8. Itching: Generalized itching (pruritus) without a rash, which can be quite bothersome.
9. Skin Changes: In some cases, NHL can present with skin rashes, lesions, or lumps.

It’s important to note that these symptoms can be caused by other health conditions as well; experiencing one or more of these symptoms doesn’t necessarily mean an individual has NHL. However, if symptoms persist or worsen, it is advisable to consult a healthcare professional for further evaluation.

Several factors can increase the risk of developing Non Hodgkin lymphoma (NHL):

1. Age: The risk of NHL increases with age, with most cases diagnosed in adults aged 60 and older.
2. Gender: Men are more likely to develop NHL than women.
3. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS, have a higher risk of developing NHL. Immunosuppressive treatments (e.g., for organ transplant patients) also increase risk.
4. Autoimmune Diseases: Conditions such as rheumatoid arthritis, lupus, or Sjögren’s syndrome can increase the risk due to chronic inflammation and immune activation.
5. Infections: Certain viral infections, such as the Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV), have been linked to an increased risk of developing certain types of NHL.
6. Chemical Exposure: Exposure to certain chemicals, particularly pesticides, herbicides, and solvents such as benzene, may be associated with a higher risk of NHL.
7. Family History: A family history of lymphoma or other blood cancers may increase an individual’s risk.
8. Geographic Location: Some studies suggest that living in certain geographic regions with higher pesticide use or specific environmental exposures may contribute to an increased risk.
9. Obesity: Some research indicates that obesity may be a risk factor for developing various types of lymphoma.
10. Previous Radiation Therapy: Individuals who have received radiation therapy for other cancers may have an increased risk of developing NHL later.

1. Chemotherapy:Chemotherapy is often the first-line treatment for many types of NHL. It involves the use of powerful drugs to kill cancer cells or inhibit their growth. Commonly used chemotherapy regimens include:
   • R-CHOP:A combination of rituximab (a monoclonal antibody) with cyclophosphamide, doxorubicin, vincristine, and prednisone.
   • CHOP:Similar to R-CHOP but does not include rituximab.
2. Targeted Therapy: Targeted therapies are designed to specifically attack cancer cells while minimizing damage to normal cells. Some examples include:
   • Rituximab (Rituxan):A monoclonal antibody targeting CD20-positive B-cell lymphomas.
   • Brentuximab Vedotin (Adcetris):A medication that combines an antibody with a chemotherapy drug, used for specific subtypes of NHL.
3. Immunotherapy: Immunotherapy utilizes the body’s immune system to combat cancer cells. It includes therapies such as:
4. CAR T-Cell Therapy:A groundbreaking treatment that involves modifying a patient’s own T-cells to target and destroy lymphoma cells, showing high effectiveness in certain types of aggressive NHL.
5. Nivolumab (Opdivo) and Pembrolizumab (Keytruda):Immune checkpoint inhibitors that help the immune system recognize and attack cancer cells.
6. Radiation Therapy: Radiation therapy may be used to target specific areas of lymphoma, especially for localized disease. It can be effective in combination with chemotherapy for certain patients.
7. Stem Cell Transplant: For patients with high-risk or relapsed NHL, stem cell transplantation (autologous or allogeneic) may be considered. This approach allows for the use of high-dose chemotherapy to treat the lymphoma, followed by transplanting healthy stem cells to restore the bone marrow.
8. Supportive Care: Throughout treatment, supportive care is essential to manage side effects and improve quality of life. This can include anti-nausea medications, pain management, nutritional support, and counseling services.
9. Observation (Watchful Waiting): In some cases of indolent or slow-growing NHL, especially in asymptomatic patients, a strategy of “watchful waiting” may be recommended, where treatment is delayed until symptoms arise or the disease progresses.

Conclusion

Non-Hodgkin Lymphoma comprises a diverse group of diseases, and treatment plans are personalized based on many factors, including the specific lymphoma subtype and the patient’s overall health. Early diagnosis and access to effective therapies greatly enhance treatment success rates. It’s essential for patients to discuss all available treatment options with their healthcare providers to determine the most appropriate approach for their individual situation.

1. Non Hodgkin Lymphoma:The 5-year survival rate for non-Hodgkin lymphoma varies widely based on the specific type and stage but is generally around 72%. For some aggressive subtypes, advances in treatment have improved survival rates markedly.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

The most critical warning sign of skin cancer is the appearance of a new spot on the skin or changes in an existing spot that seem abnormal. Following the A B C D E guidelines can help you identify the common signs of skin cancer:

• Asymmetry:One half of a mole (or birthmark) does not match the other half.
• Border:Edges are irregular, ragged, notched, or blurred.
• Color:The color is uneven, often featuring different shades of brown or black, along with patches of pink, red, white, or blue.
• Diameter:The spot is larger than 6 millimeters across (about the size of a pencil eraser).
• Evolving:The mole is changing in size, shape, color, or elevation. 

Skin cancer is typically identified first by a healthcare professional during an examination of an unusual area on the skin. However, determining whether it is cancerous requires removal and subsequent testing, known as a biopsy. This is the only reliable method to confirm a skin cancer diagnosis.

You may have your biopsy performed in a dermatologist’s office or as an outpatient procedure in a hospital or clinic, depending on the size and location of the abnormal area. Local anesthesia is usually administered to ensure your comfort.

There are four common types of skin biopsies:

• Punch Biopsy:A sharp, hollow tool is used to remove a circle of tissue from the abnormal area.
• Incisional Biopsy:A scalpel is employed to remove a portion of the growth.
• Excisional Biopsy:The entire growth and some surrounding tissue are removed with a scalpel.
• Shave Biopsy:A thin, sharp blade is used to shave off the abnormal growth.

If there is a possibility of melanoma, dermatologists will generally avoid simply shaving or cauterizing the growth. Instead, an excisional biopsy will be performed, or if the growth is too large, a tissue sample will be collected.

Upon receiving a biopsy confirmation of skin cancer, you will be referred to a specialized oncologist for further evaluation and care. Understanding the extent, or stage, of your cancer is crucial, whether you have melanoma or nonmelanoma skin cancer. Staging involves a meticulous assessment to determine how thick the tumor is and whether it has metastasized to other parts of the body. If the tumor is particularly thick, your doctor may recommend chest x-rays, blood tests, and imaging scans of the liver, bones, and brain.

Knowing the stage of your cancer enables your oncologist to:

• Assess the seriousness of your cancer and your chances for survival
• Formulate the most effective treatment plan for your unique situation
• Identify clinical trials that may present additional treatment options

In some cases, your oncologist may need to examine your lymph nodes to accurately stage the cancer. Surgical procedures may be part of the treatment plan to remove cancerous lymph nodes, which can aid in managing the disease.

Staging Criteria
Staging is based on several key factors:

• The size of the tumor
• How deeply it has penetrated below the surface of the skin
• Whether it has spread to nearby lymph nodes or other organs

Oncologists utilize Roman numerals I through IV to designate the cancer stage. Stage I indicates small tumors that are confined to their original site, while Stage IV signifies advanced cancer that has spread to distant sites in the body.

Nonmelanoma Skin Cancer Staging
The stages of nonmelanoma skin cancer are as follows:

• Stage 0: The cancer is localized to the top layer of skin, classified as carcinoma in situ.
• Stage I: The tumor measures 2 centimeters (approximately three-quarters of an inch) or smaller.
• Stage II: The tumor exceeds 2 centimeters in diameter.
• Stage III: The cancer has spread beyond the skin to underlying tissues such as cartilage, muscle, or bone, or to nearby lymph nodes, but not to distant locations.
• Stage IV: The cancer has metastasized to other areas in the body.

Melanoma Staging
The staging for melanoma specifically is defined as follows:

• Stage 0: Melanoma cells are confined to the outer layer of skin (epidermis) and have not invaded deeper tissues.
• Stage I: In Stage I, the melanoma is considered thin:
  • The tumor is no thicker than 1 millimeter (1/25 inch) and may show signs of ulceration (a scraped appearance).
  • Alternatively, the tumor measures between 1 and 2 millimeters thick without ulceration, and melanoma cells have not spread to nearby lymph nodes.
• Stage II: At this stage, the tumor is at least 1 millimeter thick:
  • It may be between 1 and 2 millimeters thick and present with ulceration.
  • Alternatively, the tumor may be greater than 2 millimeters thick, potentially with ulceration, but has not yet spread to nearby lymph nodes.
• Stage III: This indicates that melanoma has spread to nearby lymph nodes or to tissues just outside the original tumor without affecting the lymph nodes.
• Stage IV: At this advanced stage, melanoma cells have metastasized to other organs, lymph nodes, or distant skin areas.
• Recurrent: Recurrent disease indicates that cancer has returned after treatment, either in the original site or in a new location within the body.

There are various approaches to treating skin cancer, and your oncologist will work closely with you to determine the most effective combination of therapies based on the stage of cancer and your overall health. We at El Portal Comprehensive Cancer Centers are dedicated to providing you with comprehensive care tailored to your needs, ensuring you receive the support, guidance, and treatment necessary for your journey toward recovery.

Nonmelanoma Skin Cancer Treatments

In some cases, the entire nonmelanoma skin cancer may be removed during the biopsy, which means no further treatment is necessary. However, if additional treatment is required, your doctor will outline the available options.

There are six primary types of nonmelanoma skin cancer treatments, which may be used individually or in combination:

1. Surgery
2. Chemotherapy
3. Photodynamic therapy
4. Radiation therapy
5. Biologic therapy
6. Targeted therapy

Melanoma Skin Cancer Treatments

Melanoma treatment encompasses nearly all the same options as nonmelanoma skin cancer, with the exception of photodynamic therapy.

Skin Cancer Treatment Options

Your oncologist can provide detailed explanations of the following surgical techniques:

• Wide-Local Excision (WLE): This common approach involves numbing the area and surgically removing the cancer along with a margin of surrounding healthy skin. The margin is examined microscopically to ensure all cancer cells have been excised, and the required margin size will depend on the tumor’s dimensions. In some cases, nearby lymph nodes may also be removed.
• Mohs Surgery: This technique is particularly beneficial for skin cancer treatment. The surgeon numbs the area and removes thin layers of the tumor, examining each layer under a microscope for cancer cells. The process continues until no cancerous cells are detected, ensuring complete tumor removal while preserving as much healthy tissue as possible.
• Electrodesiccation and Curettage: This method is ideal for small basal cell skin cancers. The doctor numbs the area, removes the cancer using a curette (a spoon-shaped surgical instrument), and then employs an electric current to control bleeding and eliminate any remaining cancer cells. This procedure tends to be quick and straightforward.
• Cryosurgery: This option is suitable for patients who may not tolerate other surgical methods. Cryosurgery employs extreme cold, typically generated from liquid nitrogen, to treat early-stage or very thin skin cancer lesions. While effective, this approach may cause swelling and could damage nerves in the area, leading to temporary loss of sensation.
• Laser Surgery: This technique involves using a focused beam of light to target and destroy cancer cells. It is primarily utilized for superficial growths confined to the outer layer of skin.
• Skin Grafting: Occasionally, grafts are necessary to cover openings left by surgical removal. In this procedure, the surgeon numbs the area and removes a patch of healthy skin from another part of your body, such as the thigh, to cover the excised area. It is important to provide special care to the graft site during the healing process.
• Lymphadenectomy: This surgical procedure may be employed in the case of melanoma, wherein lymph nodes are removed for evaluation. The removed tissue is examined under a microscope for cancer cells.
• Sentinel Lymph Node Biopsy: During this procedure, the sentinel lymph node—the first node likely to receive cancer spread from the tumor—is surgically removed. A radioactive substance and/or blue dye is injected near the tumor site to track the flow to the lymph nodes. If no cancer cells are found in the sentinel node, additional nodes may not need to be excised, making this a useful technique within melanoma treatment plans.

El Portal Cancer Centers believe in a team solution customize for each patient with the primary ingredient being compassion.

Receiving a breast cancer diagnosis can feel overwhelming, filled with many appointments and decisions. It is important to remember that you are not alone. At El Portal Cancer Centers, we provide valuable resources and support to help you navigate this journey.

As you process this life-changing news, know that we stand by you, offering strength and encouragement as you navigate treatment and beyond. You can count on us to help you regain control and move forward with hope and resilience. Together, we are dedicated to supporting you through every phase of your cancer journey.

There are several methods for checking and detecting breast cancer. Here are some commonly recommended strategies:

1. Breast Self-Examination (BSE): Women can perform self-exams to familiarize themselves with the normal look and feel of their breasts. This involves checking for any unusual lumps, changes in shape, texture, or size, and reporting any concerns to a healthcare provider.

2. Clinical Breast Examination (CBE): A healthcare provider performs a physical examination of the breasts during a routine check-up. They look for any abnormalities, lumps, or changes and can provide guidance on what to watch for.

3. Mammography: This is an X-ray of the breast, and it is the most effective screening tool for early detection of breast cancer. The American Cancer Society recommends that women begin annual mammograms at age 40 or earlier, depending on individual risk factors.

4. Breast Ultrasound: This imaging test uses sound waves to create pictures of the breast tissue. It’s often used as a supplement to mammography, particularly for women with dense breast tissue or when there are abnormalities found.

5. Magnetic Resonance Imaging (MRI): Breast MRI may be used in certain high-risk individuals or to further investigate abnormalities detected during mammography or ultrasound.

6. Genetic Testing: For individuals with a strong family history of breast cancer, genetic tests (such as BRCA1 and BRCA2) can help determine susceptibility and the need for enhanced screening or preventive measures.

7. Biopsy: If a lump or abnormality is detected, a biopsy may be performed to remove a sample of breast tissue for laboratory analysis to confirm the presence of cancer cells.

Regular screening and monitoring are essential for early detection and improved treatment outcomes. Women should discuss their personal risk factors and screening plans with their healthcare providers to determine the best approach for their individual needs.

Side effects of hormone therapy can vary between men and women due to physiological differences. They may include:

• For Women (Breast Cancer Treatment): Hot flashes, vaginal dryness, mood swings, fatigue, and risk of osteoporosis.
• For Men (Prostate Cancer Treatment): Hot flashes, reduced libido, weight gain, fatigue, and risk of osteoporosis.

While hormone therapy can be a powerful tool against cancer, it’s important to understand potential risks:

• Bone Health:Long-term hormone therapy may affect bone density, leading to increased risk of fractures.
• Cardiovascular Health:Hormonal changes can impact heart health, especially in prolonged use.
• Mood and Cognitive Effects:Hormonal alterations may lead to mood swings or changes in cognitive function.
• Metabolic Changes:There may be a risk of weight gain or changes in metabolism, affecting energy levels.

Hormone therapy offers a vital route to managing and treating certain cancers, personalized to each patient’s needs and circumstances. Patients are encouraged to maintain open communication with their healthcare providers, ensuring that they fully understand the benefits and possible impacts of treatment. With comprehensive care and support, hormone therapy can contribute positively to a patient’s cancer journey.

While the precise causes of leukemia remain unclear, certain factors have been identified that may increase the likelihood of developing the disease.

Known Risk Factors for Leukemia Include:

• Genetic Factors: Individuals with certain genetic syndromes, such as Down syndrome, are at higher risk for leukemia. Specific inherited genes may also predispose individuals to developing the disease.
• Environmental Exposure: Long-term exposure to high levels of radiation—such as that from nuclear accidents—or exposure to chemicals like benzene (found in cigarette smoke and industrial emissions) has been linked to an increased risk of leukemia.
• Age: The incidence of leukemia increases with age, though acute forms can occur in children as well.
• Family History: Individuals with a family history of leukemia or other blood cancers are at a higher risk, indicating a potential genetic component.
• Previous Cancer Treatment: Those who have undergone chemotherapy or radiation for other cancers may have an elevated risk of developing leukemia later on.

Leukemia can present with a variety of symptoms, which may vary based on the type but commonly include:

• Fatigue or Weakness: A significant drop in red blood cells can lead to anemia, causing chronic fatigue, dizziness, and weakness.
• Frequent Infections: Abnormal white blood cells can interfere with the immune system, resulting in increased susceptibility to infections.
• Easy Bruising or Bleeding: Low platelet counts can impair the blood’s ability to clot, leading to excessive bruising, nosebleeds, or gum bleeding.
• Unexplained Weight Loss: Many patients experience unintentional weight loss as a result of the body’s heightened metabolic need in response to the disease.
• Night Sweats: Some individuals experience drenching sweats at night, often accompanying fever and chills.
• Pain in the Bones or Joints: Some forms of leukemia.

Diagnosis of Leukemia

Diagnosing leukemia typically involves a combination of medical history, physical examination, and specific tests, including:

• Blood Tests:To look for abnormal levels of white blood cells, red blood cells, and platelets.
• Bone Marrow Biopsy:A definitive test to confirm leukemia and identify its type.
• Imaging Tests:Such as CT scans or MRIs, to assess any organ involvement.

Leukemia Treatment Options

Treatment for leukemia is tailored to the type and stage of the disease but may include:

• Chemotherapy:The primary treatment for most types of leukemia, aiming to kill cancer cells.
• Radiation Therapy:Used to target specific areas and relieve symptoms.
• Targeted Therapy:Drugs that specifically target cancer cell growth signals.
• Stem Cell Transplant:Harvesting healthy stem cells to replace diseased bone marrow.

Staging is an essential process that helps determine the extent of the disease and guide treatment options.

Chronic Lymphocytic Leukemia (CLL) Stages

CLL is typically classified into the following stages:

1. Stage 0: Low-risk; increased lymphocyte count without symptoms.
2. Stage I: Enlarged lymph nodes.
3. Stage II: Enlarged lymph nodes and spleen or liver.
4. Stage III: Anemia due to low red blood cell counts.
5. Stage IV: Low platelet counts and significant complications.

Rai Staging System

The Rai Staging System is a common method to categorize CLL, based on physical examination and blood test results, including the number of lymphocytes and the presence of anemia or low platelet levels.

Chronic Myeloid Leukemia (CML) Stages

CML has three phases:

1. Chronic Phase: Slow growth, often asymptomatic at diagnosis.
2. Accelerated Phase: Disease begins to evolve, with signs of progression.
3. Blastic Phase: Rapid growth, resembling acute leukemia and requiring urgent treatment.

Medical History Review: The hematologist will ask detailed questions regarding your medical history, family history, and any symptoms you’ve been experiencing. Be prepared to provide information on previous illnesses, medications, and treatments you have received.

Physical Examination: A physical exam will often be performed to assess your overall health and identify any signs of hematologic disorders. This may include checking for signs of anemia, swelling in lymph nodes, or other related symptoms.

Diagnostic Tests: You may undergo blood tests or, in some cases, a bone marrow biopsy to determine the nature of your condition. If you already have recent test results, bring copies.

Discussion of Symptoms: You’ll have the opportunity to discuss any symptoms you have been experiencing, such as fatigue, infections, or bleeding. Be specific about the duration and severity of each symptom.

Treatment Plan Discussion: Based on your diagnostic results, the hematologist will discuss potential treatment options, including the benefits and risks associated with each.

Referrals and Additional Tests: If needed, you may be referred to other specialists, or additional diagnostic tests may be scheduled.

When meeting with the hematologist, it’s essential to have your questions ready. Here are some key questions that can guide the conversation:

Diagnosis Clarification:

• What specific type of hematologic condition do I have?
• How was this diagnosis determined?

Implications of Diagnosis:

• What does my diagnosis mean for my health?
• Are there any associated risks or complications?

Symptoms and Management:

• What symptoms should I watch for that would require immediate medical attention?
• Are there any lifestyle changes I should consider to manage my condition?

Treatment Options:

• What treatments are available for my condition, and which do you recommend?
• What are the potential side effects of each treatment option?
• How long will treatment last, and what does it involve?

Prognosis:

• What is the prognosis for my condition?
• How often will I need follow-up appointments or tests?

Support Resources:

• Are there support groups or resources you recommend for patients with similar diagnoses?
• How can I get in touch with a nutritionist or mental health professional if needed?

Questions Regarding Future Visits:

• How frequently will I need to return for follow-ups?
• What tests or evaluations will be conducted during future visits?

Additional Tips for Your Appointment

• Bring a Support Person: Consider bringing a family member or friend for support. They can help take notes and remember information discussed during the appointment.
• Prepare a List: Write down your symptoms, concerns, and any medications you are currently taking. This preparation can ensure that you don’t forget important details during the visit.
• Be Honest: Feel free to share your emotional state or any fears you may have regarding your health. Hematologists are trained to address both physical and emotional aspects of care.
• Follow-up Questions: Don’t hesitate to ask for clarification if you don’t understand something. It’s essential to have a clear understanding of your diagnosis and treatment plan.

By preparing thoughtfully for your first hematologic oncology appointment and asking the right questions, you’ll be better positioned to address your health concerns and collaborate effectively with your healthcare team.

Diagnosing Multiple Myeloma typically involves several steps:

1. Medical History and Physical Examination:
   • Your healthcare provider will start by reviewing your medical history, discussing symptoms you’ve experienced, and conducting a thorough physical examination to check for signs of the disease, such as bone tenderness or swelling.
2. Blood Tests:
   • Blood tests are essential in diagnosing Multiple Myeloma. Common tests include:
     • Complete Blood Count (CBC): Monitors levels of red blood cells, white blood cells, and platelets.
     • Blood Chemistry Tests: Assess kidney function and other vital parameters.
     • Serum Protein Electrophoresis (SPEP): Identifies abnormal proteins (monoclonal proteins) produced by myeloma cells.
     • Free Light Chain Assay: Measures the levels of free light chains in the blood and can indicate the presence of myeloma.

3. Urine Tests:
   • A 24-hour urine collection may be performed to check for Bence Jones protein, a type of light chain protein released by myeloma cells.
4. Bone Marrow Biopsy:
   • A definitive diagnosis often requires a bone marrow biopsy, where a small amount of bone marrow (usually from the hipbone) is extracted and analyzed for abnormal plasma cells.
5. Imaging Tests:
   • Imaging techniques such as X-rays, CT scans, or MRIs are used to assess bone damage or lesions caused by myeloma. These tests help identify areas of bone weakening or fractures.

While the exact cause of Multiple Myeloma remains unknown, several factors may increase the risk:

1. Age: The risk of developing Multiple Myeloma increases with age, most commonly affecting individuals over 65.
2. Gender: Men are more likely to develop Multiple Myeloma than women.
3. Race: African Americans have a higher incidence of Multiple Myeloma compared to Caucasian populations.
4. Family History: A family history of Multiple Myeloma or related plasma cell disorders may increase individual risk.
5. Certain Medical Conditions: Conditions such as monoclonal gammopathy of undetermined significance (MGUS) or other blood disorders can predispose individuals to myeloma.
6. Exposure to Chemicals: Long-term exposure to certain chemicals, such as benzene, and agricultural chemicals, may contribute to the development of myeloma.

Recognizing the signs and symptoms of Multiple Myeloma is crucial for early intervention:

1. Bone Pain: Persistent pain, particularly in the back, hips, or ribs, may indicate damage to the bones caused by myeloma lesions.
2. Fatigue: Anemia, caused by reduced red blood cell production, often leads to fatigue and weakness.
3. Frequent Infections: Compromised immune function due to myeloma can make patients more susceptible to infections.
4. Unexplained Weight Loss: Patients may experience unexplained weight loss with no changes in their regular diet or physical activity.

Treatment for Multiple Myeloma is generally tailored to individual patient needs and the disease’s specific characteristics. Here are the primary treatment options:

1. Chemotherapy: Chemotherapy remains a cornerstone of treatment for Multiple Myeloma. Regimens may include combinations such as:
   • Bortezomib (Velcade):A proteasome inhibitor that blocks protein degradation pathways in cancer cells.
   • Dexamethasone:A corticosteroid used in combination with other drugs to reduce inflammation and manage symptoms.
   • Lenalidomide (Revlimid):An immunomodulatory drug that enhances the immune response against myeloma cells.
2. Targeted Therapy: Targeted therapies focus specifically on cancerous cells, minimizing harm to normal cells:
   • Monoclonal Antibodies:Medications like daratumumab (Darzalex) are designed to target specific proteins on myeloma cells, leading to their destruction.
   • Carfilzomib (Kyprolis):A newer proteasome inhibitor used in patients with relapsed or refractory myeloma.
3. Immunotherapy: Immunotherapies use the body’s immune system to fight cancer:
   • Chimeric Antigen Receptor (CAR) T-Cell Therapy:This innovative approach involves modifying a patient’s T-cells to better recognize and attack myeloma cells. It has shown promise for some patients with difficult-to-treat myeloma.
4. Stem Cell Transplant: For eligible patients, stem cell transplant can provide an opportunity for long-term remission:
   • Autologous Stem Cell Transplant:This involves harvesting the patient’s own stem cells, administering high-dose chemotherapy to eliminate cancer cells, and then reinfusing the healthy stem cells.
5. Radiation Therapy: Radiation can be used to relieve pain or target specific areas affected by multiple myeloma, particularly in cases of localized disease or bone lesions.
6. Supportive Care: Supportive care plays a vital role in managing symptoms and improving quality of life. This may include medications for pain relief, management of anemia, hydration support, and nutritional counseling.

During radiation therapy, a team led by a radiation oncologist—a specialist in this treatment—will carefully plan and supervise your treatment. Each session typically involves directing high-energy radiation toward the cancer cells using specialized equipment. This targeted exposure fractures the DNA within the cancer cells, making it difficult for them to grow and multiply. While healthy surrounding cells may also be exposed to some radiation, most can recover and continue functioning normally, whereas cancer cells generally cannot.

At El Portal Comprehensive Cancer Centers, we utilize the latest and most advanced radiation technologies to minimize exposure to healthy cells. Our accredited equipment undergoes daily checks to ensure the highest level of precision in treatment.

There are two main categories of radiation therapy:

External Beam Radiation Therapy

This method delivers radiation from a machine outside the body, directing beams specifically at the cancer site. The equipment does not physically contact the body and can be adjusted to deliver radiation from multiple angles. Treatment typically occurs five days a week for a duration ranging from 1 to 10 weeks.

Technologies may include:

• TrueBeam Radiotherapy:Offers advanced options tailored to your specific anatomy and cancer type.
• Image-guided Radiation Therapy (IGRT):Uses imaging (such as CT or ultrasound) to accurately direct radiation.
• Intensity-modulated Radiation Therapy (IMRT):Shapes radiation beams around tumors while sparing surrounding healthy organs.
• Stereotactic Radiosurgery (SRS):A non-invasive approach treating irregularly shaped tumors, particularly in the brain.
• Stereotactic Body Radiation Therapy (SBRT):Similar to SRS, but designed for tumors outside the skull.
• Hypofractionated Radiation Therapy:A specialized technique for breast cancer treatment, depending on individual patient factors.

Internal Radiation Therapy

Internal radiation therapy, or brachytherapy, involves placing radioactive material directly inside or near the tumor. This may include various implants such as pellets, seeds, or tubes, which are inserted using minimally invasive methods.

At El Portal Comprehensive Cancer Centers, we offer:

• High-Dose Rate (HDR) Brachytherapy:Often utilized for uterine or cervical cancers, this approach involves placing radioactive material for short durations multiple times.
• Selective Internal Radiation Therapy (SIRT):An innovative, non-surgical procedure for liver tumors, delivered via tiny radioactive beads inserted directly into blood vessels leading to the tumor.

After a cancer diagnosis, you will likely be referred to a cancer specialist, such as a surgical oncologist or medical oncologist. Your treatment plan, which may include radiation therapy, is tailored uniquely based on:

• Type and grade of cancer
• Size and location of the tumor
• Sensitivity of surrounding tissue
• Genetic components
• Family history
• Age, overall health, and medical background
• Personal treatment goals and preferences

Your doctor will also consider whether you have previously received radiation to that area, as each body part has a safe lifetime dose of radiation. The decision to proceed with radiation for recurrence depends on the location of the tumor, cancer type, and past radiation exposure.

Radiation therapy may be recommended as a standalone treatment or in conjunction with surgeries, chemotherapy, or immunotherapy. At El Portal Comprehensive Cancer Centers, we typically can schedule your first appointment within two days of your referral.

Radiation therapy demands a high degree of skill, precision, and experience. Selecting a provider with state-of-the-art technology and strict protocols ensuring equipment accuracy is essential.

At El Portal Comprehensive Cancer Centers, we have been delivering high-quality radiation therapy for patients across California for over 15 years. Our board-certified radiation oncologists bring expertise and compassion to your care.

Key factors to consider include:

• Technology:Choose a center equipped with the most advanced equipment for optimal treatment.
• Experience:Our dedicated team ensures patients receive knowledgeable and compassionate care.
• Affordability:As the largest community-based cancer center, we strive to provide services in a cost-effective

Caring for someone with cancer can make maintaining your own health seem difficult. To effectively care for your loved one, it’s vital to schedule time for your own medical appointments and self-care routines. Prioritizing your health ensures you have the strength and energy to continue providing support. Incorporate self-care practices such as maintaining a balanced diet, getting adequate sleep, engaging in regular physical activity, and practicing relaxation techniques like deep breathing or meditation.

There are resources to help you stay physically active and connected to the world around you. If you need help finding services in your area, contact an EPCC social worker.

The emotional toll of caregiving can lead to feelings of isolation and exhaustion. The following resources can help nurture your emotional well-being and provide strategies for maintaining balance while caring for your loved one.

Our social workers are available to offer counseling and connect you with local support services. To speak with a licensed social worker, contact your nearest EPCC location during business hours.

Important: In case of an emergency, do not leave a message—call 911 directly.

Connecting with others and carving out time for yourself can be difficult. Getting assistance with everyday tasks can free up energy and reduce stress.

• Reducing Stress and Anxiety: Share your feelings with family and friends so they understand your needs. Consider designating one or two people as primary contacts to communicate important updates or coordinate help.
• Organizing Support: Organizing support for cancer patients can make a significant difference in their quality of life and treatment experience. Here are some ideas:

• Create a Care Calendar or Schedule: Use tools like Lotsa Helping Hands or a shared online calendar to coordinate tasks such as meal preparation, transportation, errands, and childcare.
• Designate Support Roles: Assign specific responsibilities to friends or family members—e.g., one person manages appointments, another handles meals, and someone else provides emotional support.
• Use Digital Platforms: Set up a private CaringBridge site or Facebook group for updates, sharing needs, and organizing volunteer efforts.
• Meal Train: Organize a meal delivery schedule through services like MealTrain.com to ensure consistent nutritious meals.
• Transportation Assistance: Coordinate rides to treatment appointments through community programs, local volunteer driver services, or rideshare apps.
• Host Support Groups: Establish or join local or virtual support groups for patients and caregivers to share experiences and advice.
• Organize Practical Help: Arrange for cleaning services, home repairs, or pet care through local providers or community resources.
• Spiritual and Emotional Support: Connect with local chaplain services, spiritual care providers, or mental health counselors who can offer guidance and comfort.
• Fundraising and Resources: Set up crowdfunding campaigns or organize community fundraising events to support medical expenses or related needs.
• Encourage Self-Care and Reflection: Support the patient in incorporating activities like meditation, journaling, or nature walks into their routine, and facilitate access to these resources.

Implementing even a few of these strategies can greatly ease the burden on patients and caregivers, fostering a supportive community around their treatment and recovery.

Resources in Your Area:

• Meal Delivery: Meals on Wheels — check their website for local providers.
• Transportation: Local transportation services in the Central Valley, or the American Cancer Society Road to Recovery (800-227-2345).
• Cleaning Services:
  Modesto:
  MaidPro Modesto — Professional cleaning services including residential and light commercial cleaning.
  Sweet Home Cleaning — Offers regular and deep cleaning options for homes.
  
  Merced:
  Maid in Merced — House cleaning services with flexible scheduling.
  Merced Cleaning Service — Residential cleaning, move-in/move-out cleaning, and special deep cleaning.
  
  Manteca:
  Manteca Cleaning Service — Residential and commercial cleaning, including carpet and upholstery cleaning.
  Simply Clean Manteca — Home cleaning services tailored to your needs.

Please note that it’s advisable to verify current availability, reviews, and insurance coverage before hiring any service.

• Home Care Support: Consult your medical team for referrals suitable to your needs, with local providers available in Modesto, Merced, and Manteca.

Spirituality can mean different things to each person, often related to finding purpose and connection in life. As a caregiver, taking time for reflection and nurturing your spirit is essential but can be overlooked.

Resources and practices such as meditation, guided visualization, journaling, spending time in nature, or connecting with a spiritual care provider can be helpful.

Connecting with Spiritual Support:
Start by contacting your local hospital’s pastoral care or chaplain services. They can connect you with a non-denominational chaplain or spiritual counselor who can offer support and guidance aligned with your beliefs or preferences.

If you need additional assistance or specific resources tailored to your area, please contact a social worker at your EPCC location.